Placental and mammary transfer of sulphasalazine.
作者信息
Khan A K, Truelove S C
出版信息
Br Med J. 1979 Dec 15;2(6204):1553. doi: 10.1136/bmj.2.6204.1553.
Abstract
摘要
相似文献
1
Placental and mammary transfer of sulphasalazine.柳氮磺胺吡啶的胎盘转运及乳腺转运
Br Med J. 1979 Dec 15;2(6204):1553. doi: 10.1136/bmj.2.6204.1553.
2
Sulphasalazine treatment during breast feeding.
Scand J Gastroenterol. 1979;14(7):869-71. doi: 10.3109/00365527909181418.
3
Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites.
Scand J Gastroenterol. 1981;16(5):693-7. doi: 10.3109/00365528109182032.
4
5
Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation.
Acta Paediatr Scand. 1987 Jan;76(1):137-42. doi: 10.1111/j.1651-2227.1987.tb10430.x.
6
Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development.柳氮磺胺吡啶。药理学、临床应用、毒性及相关新药研发。
Ann Intern Med. 1984 Sep;101(3):377-86. doi: 10.7326/0003-4819-101-3-377.
7
Comparative pharmacokinetics of sulphasalazine and sulphapyridine after rectal and oral administration to patients with ulcerative colitis.
Eur J Clin Pharmacol. 1984;26(2):275-7. doi: 10.1007/BF00630300.
8
Albumin reserve for binding of bilirubin in maternal and cord serum under treatment with sulphasalazine.柳氮磺胺吡啶治疗下母体和脐带血清中胆红素结合的白蛋白储备
Scand J Gastroenterol. 1981;16(8):1049-55. doi: 10.3109/00365528109181027.
9
Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis.柳氮磺胺吡啶在溃疡性结肠炎治疗中代谢情况的进一步研究。
Br Med J. 1977 Oct 22;2(6094):1057-9. doi: 10.1136/bmj.2.6094.1057.
10
Disposition of salicylazosulfapyridine (Azulfidine) and metabolites in human breast milk.
Dev Pharmacol Ther. 1980;1(1):31-9.
引用本文的文献
1
Pregnancy in Patients with Inflammatory Bowel Diseases-A Literature Review.炎症性肠病患者的妊娠——文献综述
Life (Basel). 2023 Feb 9;13(2):475. doi: 10.3390/life13020475.
2
Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.接受免疫抑制治疗的免疫介导性疾病患者的疫苗接种指南
J Cutan Med Surg. 2019 Jan/Feb;23(1):50-74. doi: 10.1177/1203475418811335. Epub 2018 Nov 21.
3
Managing IBD Therapies in Pregnancy.孕期炎症性肠病的治疗管理
Curr Treat Options Gastroenterol. 2017 Mar;15(1):71-83. doi: 10.1007/s11938-017-0123-5.
4
Treatment of pregnant women with a diagnosis of inflammatory bowel disease.对诊断为炎症性肠病的孕妇进行治疗。
World J Gastrointest Pharmacol Ther. 2016 Nov 6;7(4):490-502. doi: 10.4292/wjgpt.v7.i4.490.
5
Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management.妊娠与炎症性肠病：当前观点、风险及患者管理
World J Gastrointest Pharmacol Ther. 2015 Nov 6;6(4):156-71. doi: 10.4292/wjgpt.v6.i4.156.
6
Effects and treatment of inflammatory bowel disease during pregnancy.妊娠期炎症性肠病的影响与治疗
Can Fam Physician. 2008 Jul;54(7):981-3.
7
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.欧洲关于克罗恩病诊断与管理的循证共识：特殊情况
Gut. 2006 Mar;55 Suppl 1(Suppl 1):i36-58. doi: 10.1136/gut.2005.081950c.
8
Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy.孕期炎症性肠病的治疗：药物治疗的风险与安全性
Drug Saf. 1999 Oct;21(4):311-23. doi: 10.2165/00002018-199921040-00006.
9
Optimisation of antirheumatic drug treatment in pregnancy.孕期抗风湿药物治疗的优化
Clin Pharmacokinet. 1994 Dec;27(6):486-503. doi: 10.2165/00003088-199427060-00006.
10
Placental transfer of drugs administered to the mother.药物经母体的胎盘转运
Clin Pharmacokinet. 1995 Mar;28(3):235-69. doi: 10.2165/00003088-199528030-00005.
本文引用的文献
1
Distribution studies of salicylazosulfapyridine and its metabolites.柳氮磺胺吡啶及其代谢产物的分布研究。
Gastroenterology. 1973 Feb;64(2):240-5.
2
Absorption, metabolism, and excretion of salicylazosulfapyridine in man.柳氮磺胺吡啶在人体中的吸收、代谢及排泄
Clin Pharmacol Ther. 1972 Jul-Aug;13(4):539-51. doi: 10.1002/cpt1972134539.
3
4
Determination of salicylazosulphapyridine in biological materials.
Acta Pharm Suec. 1973 May;10(2):107-10.
5
Determination of sulphapyridine and its metabolites in biological materials after administration of salicylazosulphapyridine.柳氮磺胺吡啶给药后生物材料中磺胺吡啶及其代谢产物的测定
Acta Pharm Suec. 1973 Mar;10(1):87-92.
Zotero 插件